Tuesday, May 20, 2025
spot_img

22nd Century to Present at the Emerging Growth Conference on May 21, 2025

MOCKSVILLE, N.C., May 19, 2025 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a tobacco products company that is leading the fight against nicotine and believes smokers should have a choice about their nicotine consumption, (the “Company”) is pleased to announce that Larry Firestone, Chief Executive Officer, will present a brief corporate update at the Emerging Growth Conference on Wednesday, May 21, 2025, at 12:00 pm Eastern Time.

Mr. Firestone will provide updates to recent company advancements and may subsequently open the floor for questions. Questions may be submitted in advance to [email protected].

Investors can register in advance to attend the conference and receive any updates at: https://goto.webcasts.com/starthere.jsp?ei=1709483&tp_key=7518636947&sti=xxii

If attendees are not able to join the event live on the day of the conference, an archived webcast will also be made available on EmergingGrowth.com and on the Emerging Growth YouTube Channel, http://www.YouTube.com/EmergingGrowthConference.

About 22nd Century Group, Inc.
22nd Century Group is the pioneering nicotine harm reduction company in the tobacco industry enabling smokers to take control of their nicotine consumption. 

We created our flagship product, the VLN® cigarette, to give traditional cigarette smokers an authentic and familiar alternative that helps them take control of their nicotine consumption. VLN® cigarettes have 95% less nicotine than the traditional cigarette and have been proven to greatly reduce nicotine consumption. Instead of offering new ways of delivering nicotine to addicted smokers, we offer smokers the option to take control of their nicotine consumption and make informed and more productive choices, including the choice to avoid addictive levels of nicotine altogether. 

Our wholly owned subsidiaries include a leading cigarette manufacturer that produces all VLN® products and provides turnkey contract manufacturing for other tobacco brands both domestically and internationally. The 60,000 square foot facility in Mocksville, North Carolina has the capacity to produce more than 45 million cartons of combusted tobacco products annually with additional space for expansion. 

Our proprietary reduced nicotine tobacco blends are made possible by comprehensive and patented technologies that regulate nicotine biosynthesis activities in the tobacco plant, resulting in full flavor and high yield with 95% less nicotine. Our extensive patent portfolio has been developed to ensure we have the only low nicotine combustible cigarette in the United States and critical international markets.

VLN® is a registered trademark of 22nd Century Limited LLC.

Learn more at xxiicentury.com, on X (formerly Twitter), on LinkedIn, and on YouTube.

Learn more about VLN® at tryvln.com.

Investor Relations & Media Contact
Matt Kreps
Investor Relations
22nd Century Group
[email protected]
214-597-8200

Powered by SlickText.com

Hot this week

Statement Regarding Response to Press Speculation

Not for Release, Publication or Distribution, Directly or Indirectly,...

EVS Communicates the Results of the Ordinary General Meeting

EVS COMMUNICATES THE RESULTS OF THE ORDINARY GENERAL MEETING...

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; May 20, 2025 –...

Kering: Bond issue for a total amount of EUR 750 million

Press release - Bond issue - May 2025 ...

Topics

Statement Regarding Response to Press Speculation

Not for Release, Publication or Distribution, Directly or Indirectly,...

EVS Communicates the Results of the Ordinary General Meeting

EVS COMMUNICATES THE RESULTS OF THE ORDINARY GENERAL MEETING...

Capital Increase in Genmab as a Result of Employee Warrant Exercise

Company Announcement COPENHAGEN, Denmark; May 20, 2025 –...

Kering: Bond issue for a total amount of EUR 750 million

Press release - Bond issue - May 2025 ...

Net Asset Value(s)

Octopus AIM VCT plc Net Asset Value ...

Santhera’s Shareholders Approve all Board Proposals at Today’s Annual General Meeting

Pratteln, Switzerland, May 20, 2025 – Santhera Pharmaceuticals (SIX:...

Statkraft applies for licence to build new Aura power plant in Norway

Statkraft is applying for a licence to build a...
spot_img

Related Articles

Popular Categories

spot_img